Skip to main content

Day: April 10, 2025

Vivid Seats Debuts 2025 Trending Music Festival Guide

Report reveals best bucket list music festivals with ticket buying tips for fans CHICAGO, April 10, 2025 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today released its Trending Music Festival Guide for the 2025 music festival season. The report analyzes Vivid Seats’ ticket data to find the music festivals with the most buzz this year, how far festival fans are traveling, and essential ticket buying tips. By looking at single-day and multi-day pass purchases, Vivid Seats has ranked out the most popular music festivals that should be on everyone’s radar this year. Vivid Seats’ deep dive into trending music festivals shows the events that are most in-demand,...

Continue reading

VitalHub Announces Recommended Cash Acquisition of Induction Healthcare Group PLC

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) is pleased to announce that it has agreed the terms and conditions of a recommended cash acquisition to acquire all of the issued and to be issued share capital of Induction Healthcare Group PLC (“Induction”) by way of a court-sanctioned scheme of arrangement (the “Acquisition”) under Part 26 of the Companies Act 2006. Under the terms of the Acquisition, each Induction shareholder will be entitled to receive £0.10 in cash for each Induction share held, valuing Induction at approximately £9.7 million. Induction has released a Rule 2.7 announcement in the UK market in connection with the Acquisition, which shall be made available on the websites of Induction at www.inductionhealthcare.com and VitalHub at www.vitalhub.com,...

Continue reading

CERo Therapeutics Holdings, Inc. Announces Critical Patent Application Allowances from the U.S. Patent Office Covering Company’s Lead Compound CER-1236

Results in 17 Issued and Allowed Patent Applications Internationally with Nine Total Patent Families SOUTH SAN FRANSCISCO, Calif, April 10, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces the allowance of two patent applications submitted to the U.S. Patent and Trademark Office (USPTO), which materially expands the Company’s intellectual property portfolio. Patent Application No. 17/040,472, titled, “CELLULAR IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF,” was allowed on March 13, 2025 and provides coverage for composition of matter and methods of use coverage for the Company’s lead compound,  CER-1236. The allowed claims encompass...

Continue reading

Cycurion Announces Reginald S. Bailey, Sr Joins Board of Directors

MCLEAN, Va., April 10, 2025 (GLOBE NEWSWIRE) — Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces that industry veteran Reginald S. Bailey, Sr. has joined its Board of Directors, effective from the close of the Company’s recent de-SPAC transaction. Reginald S. Bailey is a high-performance operator that drives growth and profitability with complex operations. He is an accomplished entrepreneur with over 29 years of experience in C-suite roles to include CEO and COO. With a proven track record to scaling companies from startup to multimillion-dollar operations, Mr. Bailey combines entrepreneurial vision with disciplined leadership to deliver superior results for investors and stakeholders. In previous leadership roles and client engagements with George Washington...

Continue reading

ParaZero Extends Class C5 Certification for SafeAir System to Additional DJI Mavic 3 Models

Expanded compliance now includes Mavic 3 Pro and Mavic 3 Pro Cine, completing Class C5 coverage across core M3 series models TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced an extension of its European regulatory compliance under Class C5 for its SafeAir™ system designed for DJI’s Mavic 3 drone series. Following the recent inclusion of the Mavic 3 Pro and Mavic 3 Pro Cine submodels, ParaZero’s SafeAir system now achieves full Class C5 conformity across the following DJI Mavic 3 platforms:Mavic 3 Enterprise (Mavic 3E) Mavic 3 Thermal (Mavic 3T) Mavic 3 Pro Mavic 3 Pro CineThis certification extension follows confirmation...

Continue reading

Spirit Digital AG Confirms Ticker Listings for Ethereum and Solana Yield+ ETPs on SIX and Deutsche Börse

Zug, Switzerland, April 10, 2025 (GLOBE NEWSWIRE) — Spirit Digital AG (“Spirit”), a wholly owned subsidiary of Spirit Blockchain Capital Inc. (CSE:SPIR / OTC:SPBCF / FRA:RTFB), helping advance digital asset finance through thoughtful innovation, is pleased to announce that its first suite of Exchange Traded Products (ETPs) — the Spirit Ethereum Yield+ ETP and Spirit Solana Yield+ ETP — now have confirmed and official ticker listings on both the SIX Swiss Exchange and Deutsche Börse Xetra. This follows the March 27 announcement of the product launch and represents a key milestone in the Company’s commitment to delivering institutional-grade access to staking rewards through transparent and regulated investment vehicles. The newly confirmed ticker symbols are as follows and will be available for trading on April 10, 2025. Official...

Continue reading

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed to serve as President of the Company. Heshmatpour will retain his role as Executive Chairman, while taking on day-to-day leadership responsibilities to accelerate the Company’s strategic and clinical initiatives. “Amir’s appointment as President reflects our commitment to strong, visionary leadership as NeOnc advances its clinical programs,” said Dr. Thomas Chen, CEO of NeOnc. “His extensive experience in building and scaling companies, coupled with his deep understanding of capital markets and business development, will be...

Continue reading

Bridger Aerospace Awarded Exclusive-Use Contract by State of Montana for Innovative Wildfire Detection Aircraft

BELGRADE, Mont., April 10, 2025 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”) (NASDAQ: BAER, BAERW), announced today that, after participating in a competitive bidding process, it has been notified by the State of Montana as the successful bidder for an exclusive-use contract to provide wildfire detection and mapping using a specially modified Daher Kodiak 100 aircraft. The exclusive-use agreement includes an initial one-year term, with two optional extension years pending continued state funding. The contract provides for a minimum of 120 days of availability for a minimum annual value of $648,000 with additional days and flight hours incremental to the minimum annual value. “With this award, nearly all of Bridger’s air attack and sensor-equipped fleet is either committed or currently...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 09 04 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – [Niox]

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Danske Bank A/S(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree NIOX Group plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.